| 1 |
human immunodeficiency virus type 1
(16866 times)
|
Virology
(5384 times)
|
RT (883 times)
AIDS (637 times)
LTR (472 times)
|
1987 Relation of HTLV-4 to simian and human immunodeficiency-associated viruses.
|
| 2 |
HIV type 1
(682 times)
|
Virology
(250 times)
|
HIV (343 times)
RT (32 times)
ART (30 times)
|
1988 Influence of human immunodeficiency virus antibody testing on sexual behaviour in a "high-risk" population from a "low-risk" city.
|
| 3 |
HTLV-IIIB
(18 times)
|
Virology
(4 times)
|
HIV (3 times)
PBMCs (2 times)
PP (2 times)
|
1988 Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection.
|
| 4 |
HIV-1mt
(11 times)
|
Microbiology
(3 times)
|
CA (3 times)
PBMCs (2 times)
CMsTC (1 time)
|
1999 Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay.
|
| 5 |
HTLV-IIIB strain
(4 times)
|
Nursing
(2 times)
|
HIV (1 time)
|
1990 In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis.
|
| 6 |
anti-HIV type 1
(3 times)
|
Drug Therapy
(1 time)
|
BLT (1 time)
HBV (1 time)
HSPC (1 time)
|
2009 Telbivudine in the treatment of chronic hepatitis B: experience in HIV type-1-infected patients naive for antiretroviral therapy.
|
| 7 |
HIV-1JR-CSF and HIV-1NL4-3
(2 times)
|
Virology
(2 times)
|
---
|
1994 Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.
|
| 8 |
human-pathogenic immunodeficiency virus type 1
(2 times)
|
Microbiology
(1 time)
|
AID (1 time)
mA3 (1 time)
MMTV (1 time)
|
2019 A Protein Antagonist of Activation-Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus.
|
| 9 |
herpes simplex virus-1
(1 time)
|
Virology
(1 time)
|
p.i (1 time)
|
1990 Induction of interleukin-1 alpha and beta gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1.
|
| 10 |
high selectivity indices with SI=1753
(1 time)
|
Biochemistry
(1 time)
|
AIDS (1 time)
HIV (1 time)
|
2019 Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity.
|
| 11 |
highly virulent D-subtype HIV type-1
(1 time)
|
Biochemistry
(1 time)
|
HIV (1 time)
LTR (1 time)
Tat (1 time)
|
2002 Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
|
| 12 |
HIV envelope transmembrane glycoproteins gp41
(1 time)
|
Microbiological Phenomena
(1 time)
|
aa (1 time)
bNAbs (1 time)
LANL (1 time)
|
2022 HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants.
|
| 13 |
HIV group
(1 time)
|
Nutritional Sciences
(1 time)
|
AIDS (1 time)
|
1998 Urinary excretion and plasma vitamin E levels in patients with AIDS.
|
| 14 |
HIV RNase H
(1 time)
|
Biochemistry
(1 time)
|
---
|
1998 Characterization of a folding intermediate from HIV-1 ribonuclease H.
|
| 15 |
HIV, HIV-C
(1 time)
|
Biochemical Phenomena
(1 time)
|
DCs (1 time)
TNTs (1 time)
|
2022 HIV-1 Trans Infection via TNTs Is Impeded by Targeting C5aR.
|
| 16 |
HIV-1 antiserum
(1 time)
|
Virology
(1 time)
|
ELISA (1 time)
|
2001 Comparison of the biological activities of human immunodeficiency virus 1 P24 and GP41 expressed in Spodoptera frugiperda cells by use of bac-to-bac system.
|
| 17 |
HIV-1 Bal
(1 time)
|
Allergy and Immunology
(1 time)
|
DCs (1 time)
|
2001 Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.
|
| 18 |
HIV-1 CRF01_AE
(1 time)
|
Virology
(1 time)
|
NIH ARRRP (1 time)
RT (1 time)
|
2013 Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
|
| 19 |
HIV-1 envelop protein MLV
(1 time)
|
Biotechnology
(1 time)
|
---
|
2005 Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
|
| 20 |
HIV-1 replication and virus
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2003 HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children.
|
| 21 |
HIV-1 seropositive
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
M-MDSCs (1 time)
|
2016 Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.
|
| 22 |
HIV-1 TaqMan test v1.0
(1 time)
|
Virology
(1 time)
|
---
|
2010 Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach.
|
| 23 |
HIV-1-antigens, we generated a MLV
(1 time)
|
Biotechnology
(1 time)
|
RhPBMCs (1 time)
|
2006 Retroviral vectors for vaccine development: induction of HIV-1-specific humoral and cellular immune responses in rhesus macaques using a novel MLV(HIV-1) pseudotype vector.
|
| 24 |
HIV-1-LTR
(1 time)
|
Cell Biology
(1 time)
|
PBLs (1 time)
|
1996 Activation of the transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat by autologous and heterologous cell-to-cell contact.
|
| 25 |
HIV-1-WI3
(1 time)
|
Science
(1 time)
|
---
|
1989 Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
|
| 26 |
HIV-1DeltaVif
(1 time)
|
Virology
(1 time)
|
A3A (1 time)
A3G (1 time)
CDA (1 time)
|
2008 Functional domain organization of human APOBEC3G.
|
| 27 |
HIV-1HTLV-IIIB
(1 time)
|
Virology
(1 time)
|
Env (1 time)
HIV-2 (1 time)
RIPA (1 time)
|
1990 Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
|
| 28 |
HIV-1IIIB and HIV-1RF
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
ADCC (1 time)
ELISA (1 time)
MACS (1 time)
|
1990 Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
|
| 29 |
HIV-1LAI
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
F-ddA (1 time)
P119S (1 time)
RT (1 time)
|
1997 In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.
|
| 30 |
HIV-1RF
(1 time)
|
Virology
(1 time)
|
---
|
1992 A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.
|
| 31 |
HIV-1SF2, HIV-1Mck and HIV-1LAI
(1 time)
|
Allergy and Immunology
(1 time)
|
HUVEC (1 time)
|
1995 Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.
|
| 32 |
HIV-1Tg
(1 time)
|
Cells
(1 time)
|
CNS (1 time)
cSTR (1 time)
FCtx (1 time)
|
2022 Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.
|
| 33 |
HIV-GFP
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
APOBEC3G (1 time)
FACS (1 time)
MDMs (1 time)
|
2013 M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication.
|
| 34 |
HIV-positive patients, intense immunoexpression of S-100 and p24
(1 time)
|
Cell Biology
(1 time)
|
CBLL (1 time)
FNA (1 time)
HIV (1 time)
|
1999 HIV-1 (p24)-positive multinucleated giant cells in HIV-associated lymphoepithelial lesion of the parotid gland. A report of two cases.
|
| 35 |
HIV1-BaL, HIV1-JRFL and HIV1-631
(1 time)
|
Biochemistry
(1 time)
|
ADC (1 time)
IDO (1 time)
LA (1 time)
|
2000 Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1.
|
| 36 |
HIVmPIr
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
PIs (1 time)
|
2010 Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.
|
| 37 |
HLA-B*3501-predicted epitopes covered 0.9
(1 time)
|
Allergy and Immunology
(1 time)
|
ANN (1 time)
BIMAS (1 time)
|
2002 Large-scale computational identification of HIV T-cell epitopes.
|
| 38 |
HTLV-III B LAI
(1 time)
|
Biochemistry
(1 time)
|
---
|
2003 Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones.
|
| 39 |
HTLV-IIIB and HTLV-IIIRF
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
---
|
1989 Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135).
|
| 40 |
human immuno-virus-1
(1 time)
|
Chemistry
(1 time)
|
Gly-Val-SQV (1 time)
P-gp (1 time)
SQV (1 time)
|
2007 Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
|
| 41 |
HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1
(1 time)
|
Virology
(1 time)
|
ART (1 time)
|
2016 [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
|
| 42 |
human immunodeficiency virus type 1 long terminal repeat LTR
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
CAT (1 time)
LTR (1 time)
|
1992 Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation.
|
| 43 |
Human immunodeficiency virus-1 and -2
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
AIDS (1 time)
EBV (1 time)
HBV (1 time)
|
2005 AIDS related viruses, their association with leukemia, and Raf signaling.
|
| 44 |
human immunodeficiency virus-1, LAV-1 strain
(1 time)
|
Cell Biology
(1 time)
|
---
|
1990 Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
|
| 45 |
Human monoclonal antibodies to type 1 immunodeficiency virus
(1 time)
|
Virology
(1 time)
|
---
|
2003 [Construction and screening of type 1 human immunodeficiency virus specific phage antibodies combinatorial library].
|
| 46 |
Human rhinovirus type 14:human immunodeficiency virus type 1
(1 time)
|
Virology
(1 time)
|
HRV14 (1 time)
|
1998 Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.
|
| 47 |
human virus type 1
(1 time)
|
Rheumatology
(1 time)
|
PCR (1 time)
RA (1 time)
SLE (1 time)
|
1995 Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases.
|
A Search Service for Abbreviation / Long Form